BMS spends $200m to buy bluebird out of CAR-T payments
With the partners’ CAR-T therapy under review by the FDA, BMS chooses to purchase bluebird’s royalty rights and take control of ex-US manufacturing.
Archives for May 12, 2020
Pfizer to outsource brand products, making space for COVID-19 vaccine
Pfizer looks to outsource more of its vaccine and intravenous drugs to free up capacity for potential COVID-19 vaccine.
Novavax receives record $388m funding for COVID-19 vaccine
CEPI awards Novavax highest investment to date, with the biotech progressing candidate into trials and partners with Emergent for production.